Good manufacturing practice-grade production of unrestricted somatic stem cell from fresh cord blood.

@article{Aktas2010GoodMP,
  title={Good manufacturing practice-grade production of unrestricted somatic stem cell from fresh cord blood.},
  author={M. Aktas and Anja Buchheiser and A. Houben and V. Reimann and T. Radke and K. Jeltsch and P. Maier and W. Zeller and G. Kogler},
  journal={Cytotherapy},
  year={2010},
  volume={12 3},
  pages={
          338-48
        }
}
BACKGROUND AIMS The discovery of unrestricted somatic stem cells (USSC), a non-hematopoietic stem cell population, brought cord blood (CB) to the attention of regenerative medicine for defining more protocols for non-hematopoietic indications. We demonstrate that a reliable and reproducible method for good manufacturing practice (GMP)-conforming generation of USSC is possible that fulfils safety requirements as well as criteria for clinical applications, such as adherence of strict regulations… Expand
Good manufacturing practice-compliant isolation and culture of human umbilical cord blood-derived mesenchymal stem cells
TLDR
This technique provides a method to obtain UCB-MSCs compliant with good manufacturing practices for clinical application and maintained their immunophenotypes, multilineage differentiation potential, and did not form tumors when injected at a high dose into athymic nude mice. Expand
Clinical-Grade Generation of Active NK Cells from Cord Blood Hematopoietic Progenitor Cells for Immunotherapy Using a Closed-System Culture Process
TLDR
It is demonstrated that large numbers of UCB stem cell-derived NK cell products for adoptive immunotherapy can be produced in closed, large-scale bioreactors for the use in clinical trials. Expand
Isolation, Culture, and Characterization of Human Umbilical Cord Blood-Derived Mesenchymal Stromal Cells.
TLDR
The procedures in this chapter are standardized protocols that were established and optimized in the authors' research laboratory; however, various modifications of the protocols are possible. Expand
Acceleration of Translational Mesenchymal Stromal Cell Therapy Through Consistent Quality GMP Manufacturing
TLDR
This review highlights the bottlenecks associated with hMSC-based therapies and proposes solutions for consistent GMP manufacturing of hMSCs starting from raw materials selection, closed and modular systems of manufacturing, characterization, functional testing, quality control, and safety testing for release criteria. Expand
GMP-grade human fetal liver-derived mesenchymal stem cells for clinical transplantation.
TLDR
This chapter has demonstrated the manufacturing of GMP-grade human fetal liver-derived mesenchymal stem cells, which must be performed in compliance with cGMP as a quality assurance system to ensure the safety, quality, and identity of cell products during translation from the basic stem cell sciences into clinical cell transplantation. Expand
Evaluation of unrestricted somatic stem cells as a feeder layer to support undifferentiated embryonic stem cells
TLDR
It is found that hUSSCs have the potential to provide ESC support from the early moments of isolation, and are a vital part of the application of human ESCs in clinical cell therapy. Expand
Potential Application of Cord Blood-Derived Stromal Cells in Cellular Therapy and Regenerative Medicine
TLDR
A clear distinction between unrestricted somatic stromal cells (USSCs) and CB-MSC has been established and functional examination of the adipogenic differentiation potential and the capacity to support haematopoiesis in vitro and in vivo is performed. Expand
Comparison of two methodologies for the enrichment of mononuclear cells from thawed cord blood products: The automated Sepax system versus the manual Ficoll method.
TLDR
An automated, closed system for enriching MNCs from cryopreserved CB units using the Sepax, which is a walk away and automated processing system, observed higher recovery of total nucleated cells, CD34+ cells, NK cells and monocytes when compared to manual enrichment. Expand
Characterization of Regenerative Phenotype of Unrestricted Somatic Stem Cells (USSC) from Human Umbilical Cord Blood (hUCB) by Functional Secretome Analysis*
TLDR
From the data, this work is convinced that USSC are a valuable tool in regenerative medicine as USSC's secretome contains a comprehensive network of trophic factors supporting nerve regeneration not only by a single process but also maintained its regenerative phenotype by a multitude of relevant biological processes. Expand
Unrestricted somatic stem cells, as a novel feeder layer: Ex vivo culture of human limbal stem cells
TLDR
Findings of present study suggest hUSSCs as a promising alternative method for 3T3 feeder layer cells, to preserve growth and stemness of LSCs ex vivo culture. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 42 REFERENCES
Generation of induced pluripotent stem cells from human cord blood.
TLDR
The generation of human iPSCs from cord blood (CB) as a juvenescent cell source is reported, showing characteristics typical of embryonic stem cells and can be differentiated into derivatives of all three germ layers, including functional cardiomyocytes. Expand
Characterization of the Optimal Culture Conditions for Clinical Scale Production of Human Mesenchymal Stem Cells
TLDR
The optimal culture conditions for the successful isolation and expansion of human MSCs in high numbers for subsequent cellular therapeutic approaches are defined. Expand
Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use.
TLDR
Growth of MSC in a FCS-free medium is feasible without addition of growth factors and ten percent AS appears at least as good as 10% FCS with regard to both isolation and expansion of human MSC, while 1% and 3% AS appear inferior. Expand
In vitro differentiation of human cord blood-derived unrestricted somatic stem cells towards an endodermal pathway.
TLDR
It is shown that USSC can differentiate in vitro into an endodermal-like cell with a phenotype similar to hepatic cells, and endodermaly differentiated USSC might be a useful alternative for cell replacement in the future. Expand
Cytokine production and hematopoiesis supporting activity of cord blood-derived unrestricted somatic stem cells.
TLDR
USSC produce functionally significant amounts of hematopoiesis-supporting cytokines and are superior to BMMSC in expansion of CD34+ cells from CB and are therefore a suitable candidate for stroma-driven ex vivo expansion of heMatopoietic CB cells for short-term reconstitution. Expand
Cord blood for tissue regeneration
TLDR
The most consistent and the most contradictory data referring to the differentiation potential of CB‐derived stem cells are explored and an outlook on their potential clinical value including and possible reprogramming into IPS cells is given. Expand
Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy.
TLDR
Ex vivo growth conditions for hMSCs are presented that reduce the FCS proteins to less than 100 ng per 100 million h MSCs, approximately a 100,000-fold reduction, which maintains their proliferative capacity and sustain their ability for multilineage differentiation. Expand
Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM.
TLDR
It is found that primary cultures of BM-derived MSC can be established with animal serum-free media containing fresh frozen plasma and platelets and can be replaced safely by FFPP in cultures of MSC for clinical purposes. Expand
Platelet lysates promote mesenchymal stem cell expansion: A safety substitute for animal serum in cell‐based therapy applications
TLDR
It is proposed that PL may be a powerful and safe substitute for FCS in development of tissue‐ and cellular‐engineered products in clinical settings using MSCs. Expand
Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification.
TLDR
MSC isolation by MNC gravity sedimentation together with culture medium supplementation with 5% of PL in a hypoxic atmosphere significantly improved MSC yield and reduced expansion time compared to the standard accepted protocols. Expand
...
1
2
3
4
5
...